Replies to post #35550 on Cytodyn Inc (CYDY)

[trding]

BP would never let Leronlimab go it alone in mono, but even if not, if mono is approved I have zero concerns.

1) Every HAART patient on the planet will quickly know about the first every approved monotherapy drug, which is a once a week injectable with little side effect.

2)Patient testimonials about the quality of life improvement will spread through the patient population like a great summer blockbuster movie.

Imagine once Leronlimab is approved, imagine not just the few reviews we have seen: patients posted here, facebook,Charlie Sheen, etc, but now thousands talking about how Leronlimab changed their life.



https://abcnews.go.com/GMA/video/charlie-sheen-life-revealing-hiv-diagnosis-44701826

https://www.poz.com/article/charlie-sheen-says-injectable-hiv-med-no-side-effects/comments

Charlie Sheen Says His New Injectable HIV Med Has No Side Effects

Good for him for finding a therapy without side effects. Mine, starting in 1997, turned me into a gargoyle.

Also, if Leronlimab stops cancer metastasis in human clinical trials, how hard will it be to sale? ZERO

[Zuess421]

Couldn't the sales force be comission only and we have a refrigerated wharehouse capable of holding product. Only thing left is shipping product to customer or hospitals.